<DOC>
	<DOC>NCT02694302</DOC>
	<brief_summary>A clinical trial of robot-assisted-gait-training (RAGT) in stroke patients to evaluate its efficacy, safety over conventional gait training.</brief_summary>
	<brief_title>Clinical Trial of Robot-assisted-gait-training (RAGT) in Stroke Patients</brief_title>
	<detailed_description>Robot-assisted-gait-training (RAGT) in stroke patients to evaluate its efficacy, safety over conventional gait training. Experimental group receives robot-assisted-gait-training and conventional gait training. Active comparator group receives conventional gait training only as the same number as the experimental group.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>Age more than 19 and under 80 Weight under 100kg Height less than 200cm Able to walk independently before onset of stroke Ischemic or hemorrhagic stroke patients Patients with motor paralysis and gait disturbance after stroke and seeking rehabilitation treatment FAC(Functional Ambulation Category) under 3 (0~2) Subacute stroke patients after 3 days and before 3 months of onset Be informed of the nature of the study and agreed on written consent voluntarily Patients taking medications or scheduled medications due to stroke Patients with contraindications to weight bearing such as fractures, etc. Uncontrolled stage 2 hypertension (systolic over 160 mmHg or diastolic more than 100mmHg) or with uncontrolled orthostatic hypotension Patients with cardiopulmonary disease or other underlying diseases that can not tolerate gait training Patients with severe skin damage and bedsore on wearing part of the trial device Pregnant or breastfeeding Participation within 30 days of the other clinical trials Patients whom the investigator considers inappropriate to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Stroke</keyword>
</DOC>